Authors




Thomas M. Maddox, MD, MSc

Latest:

Contemporary Use of Dual Antiplatelet Therapy for Preventing Cardiovascular Events

Use of dual antiplatelet therapy was modest for patients with existing cardiovascular disease for whom subgroup analysis from a landmark clinical trial suggested benefit in preventing cardiovascular events, and low for patients with multiple risk factors without established cardiovascular disease, for whom increased cardiovascular events were suggested.


Mark T. Dransfield, MD

Latest:

Implications of DRG Classification in a Bundled Payment Initiative for COPD

Diagnosis-related group coding determines eligibility for many Medicare bundled payment initiatives. This approach excluded many patients with chronic obstructive pulmonary disease likely to benefit while including others without the disease.




Peter K. Lindenauer, MD

Latest:

Association Between Length of Stay and Readmission for COPD

Among patients admitted for chronic obstructive pulmonary disease (COPD) at Veterans Affairs hospitals, hospital-level length of stay was not associated with 30-day readmission.


Julie Gazmararian, PhD, MPH

Latest:

Exploring Health Plan Perspectives in Collecting and Using Data on Race, Ethnicity, and Language

In-depth interviews were conducted with 15 health plans to explore why plans collect or forgo race, ethnicity, and language (REL) data collection efforts, and the challenges encountered with collecting and using data for quality improvement.


Fang Xia, PhD

Latest:

Is There a Relationship Between Early Statin Compliance and a Reduction in Healthcare Utilization?

Statin therapy compliance of 80% or higher during the first 2 years of treatment is associated with reduced healthcare resource utilization in the following year.


Jacqueline Vanderpuye-Orgle, PhD

Latest:

Understanding Price Growth in the Market for Targeted Oncology Therapies

The prices of targeted oncology therapies have grown substantially, but revenues have not. This is due in part to large declines in per-drug patient counts.


Kenneth E. Thorpe, PhD

Latest:

Racial Trends in Clinical Preventive Services Use, Chronic Disease Prevalence, and Lack of Insurance Before and After the Affordable Care Act

This paper examines whether the Affordable Care Act reduced the disparities in the use of clinical preventive services, chronic disease prevalence, and the number of uninsured.


Frances B. Maguire, PhD, MPH

Latest:

A Population-Based Assessment of Proton Beam Therapy Utilization in California

This population-based analysis of patients with cancer in California found significant differences in proton beam therapy use by health insurance type, race/ethnicity, and socioeconomic status.






Mashele M. Huschka, BS, RN

Latest:

Preferred Roles in Treatment Decision Making Among Patients With Cancer: A Pooled Analysis of Studies Using the Control Preferences Scale

This pooled analysis assesses preferred roles in treatment decision making, actual roles, and preferred versus actual discordance among 6 studies of patients with cancer.



Amy J. Davidoff, PhD

Latest:

ACA Medicaid Expansion Association With Racial Disparity Reductions in Timely Cancer Treatment

Medicaid expansion was associated with a reduction in the racial disparity in timely treatment of patients with advanced cancer in the United States.




Geoff Gerhardt, MPP

Latest:

HIT Press Club AJMC - Geoff Gerhardt, MPP

Geoff Gerhardt, MPP, House Ways and Means Committee, discusses his paper at the National Press Club


Donna Cryer, JD

Latest:

NASH and Liver Cancer: The New Cancer Headline

The most common primary liver cancer, hepatocellular carcinoma, is driven by fatty liver disease and is among the most prevalent and deadly of cancers driven by obesity. Rising rates of overweight and obesity parallel increased rates of obesogenic cancers, which increased 7% between 2005 and 2014.



Eric D. Newman, MD

Latest:

Impact of Primary and Specialty Care Integration via Asynchronous Communication

Geisinger’s Ask-a-Doc program, which enables direct asynchronous communication between primary and specialty care, was associated with lower healthcare utilization and cost, implying more efficient care.


Veena Shankaran, MD

Latest:

Impact of Trained Oncology Financial Navigators on Patient Out-of-Pocket Spending

Hospitals that used trained financial navigators were able to provide financial assistance for their patients with cancer, providing access to care that would otherwise be unaffordable.



Valerie A. Lewis, PhD, MA

Latest:

Organizational Influences on Healthcare System Adoption and Use of Advanced Health Information Technology Capabilities

This is the first national study to examine the relationship between healthcare system organizational characteristics and adoption of advanced health information technology capabilities.


Ying Fan, MS

Latest:

Resource Utilization With Insulin Pump Therapy for Type 2 Diabetes Mellitus

A retrospective claims analysis of managed care enrollees with type 2 diabetes mellitus showed that insulin pump therapy reduced antidiabetic drug and healthcare resource use.


Leslie A. Wright, MA

Latest:

Pharmaceuticals From Development to Practice: Learnings From an Online Curriculum

This article summarizes the outcomes from a pilot online curriculum on off-label prescribing, appraising pharmaceutical information, and talking with patients about advertised medications.

AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo